Elevated plasma levels of TGF-1 in patients with invasive prostate cancer

1. Rinker-Schaeffer, C.W., Partin, A.W., Isaacs, W.B., Coffey, D.S. & Isaacs, J.T. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25, 249−265 (1994). | PubMed  | ChemPort |
2. Dalai, B.I., Keown, P.A. & Greenberg, A.H. Im-munocytochemical localization of secreted transforming growth factor-1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathol. 143, 381−389 (1993). | PubMed  |
3. Truong, L.D. et al. Association of transforming growth factor-1 with prostate cancer: An im-munohistochemical study. Hum. Pathol. 24, 4−9 (1993). | Article | PubMed  | ISI | ChemPort |
4. Smith, J.A.Jr & Scaletsky, R. Future directions in tumor marker technology for prostate cancer. Urol. Clin. North Am. 20, 771−777 (1993). | PubMed  | ISI |
5. Thompson, T.C. Growth factors and oncogenes in prostate cancer. Cancer Cells 2, 345−354 (1990). | PubMed  | ISI | ChemPort |
6. Merz, V.W. et al. Elevated transforming growth factor-1 and b3 mRNA levels are associated with ras+ and myc- induced carcinomas in reconstituted mouse prostate: Evidence for a paracrine role during progression. Molec. Endocrinol. 5, 503−513 (1991). | ISI | ChemPort |
7. Steiner, M.S. & Barrack, E.R. Transforming growth factor-1 overproduction in prostate cancer: Effects on growth in vivo and in vitro. Molec. Endocrinol. 6, 15−25 (1992). | Article | ISI | ChemPort |
8. Ikeda, T., Lioubin, M.N. & Marquardt, H. Human transforming growth factor type b2: Production by a prostatic adenocarcinoma cell line, purification and initial characterization. Biochemistry 26, 2406−2410 (1987). | PubMed  | ISI | ChemPort |
9. Shirai, Y. et al. Elevated levels of plasma transforming growth factor-1 in patients with hepatocellular carcinoma. Jap. J. Cancer Res. 83, 676−679 (1992). | ISI | ChemPort |
10. Carter, H.B., Piantadosi, S. & Isaacs, J.I. Clinical evidence for and implications of the multistep development of prostate cancer. J. Urol. 143, 742−746 (1990). | PubMed  | ISI | ChemPort |
11. Nishiya, M., Miller, G.J., Lookner, D.H. & Craw-ford, E.D. Prostate specific antigen density in patients with histologically proven prostate carcinoma. Cancer 74, 3002−3009 (1994). | PubMed  | ISI | ChemPort |
12. Thompson, T.C. et al. Transforming growth factor 1 as a biomarker for prostate cancer. J. cell. Biochem. 16, H, 54−61 (1992).
13. Goldstein, D., O'Leary, M. & Mitchen, J. Effects of interferon beta and transforming growth factor beta on prostatic cell lines. J. Urol. 146, 1173−1177, (1991). | PubMed  | ISI | ChemPort |
14. Welch, D.R., Fabra, A. & Nakajima, M. Transforming growth factor 1 stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. natn. Acad. Sci. U.S.A. 87, 7678−7682 (1990). | ChemPort |

	Top

	Top